John T. Treace Receives Stock Award at Treace Medical Concepts Inc (TMCI) — SEC Form 4, Mar 10, 2022
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
10.8M sh
10,746,709 → 10,780,584
Equity Change
+0.3%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| John T. Treace CIK 0001856380 |
Director
CEO
10% Owner
|
John T. Treace at Treace Medical Concepts Inc
Full insider history
Bought (12 mo)
$1,351,631
Sold (12 mo)
—
More from this insider at Treace Medical Concepts Inc
| 2026-08-24 | Buy | +$246,654 | View |
| 2026-06-11 | Buy | +$210,968 | View |
| 2026-06-01 | Buy | +$177,915 | View |
| 2026-05-28 | Buy | +$340,589 | View |
| 2026-05-14 | Buy | +$375,505 | View |
Non-Derivative Securities Transactions
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $19.15 | 2022-03-08 | A - Award/Grant | 240,566 A | $0.00 | 2032-03-08 | 240,566 Common Stock | Direct |
| Stock Option (Right to Buy)F3 | $21.07 | 2022-03-08 | A - Award/Grant | 20,884 A | $0.00 | 2027-03-08 | 20,884 Common Stock | Direct |
Footnotes (5)
- F1
- Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date. Show more
- F2
- Includes 33,875 RSUs. Show more
- F3
- The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date. Show more
- F4
- The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee. Show more
- F5
- The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee. Show more
Related filings at Treace Medical Concepts Inc
Institutional Holders
13F holders · Jun 30, 2026
115
institutional managers reporting a position
Largest by reported value
- Armistice Capital, Llc $25.3M
- Bank Of America Corporation $13.2M
- Gagnon Securities Llc $12.1M
5%+ Holders · 13D/G
4 filers
-
John T. Treace 19.2%
Other insiders at Treace Medical Concepts Inc
GET /v1/forms/4/0001567619-22-006730
API docs
View Original SEC Filing